Tag Pharmacy

WARF bets big on new squad of drug hunters

“We are building a preclinical drug discovery organization,” says WARF Therapeutics Director Jon Young, who has worked in drug development at Merck Research Laboratories, Regulus Therapeutics and Celgene.

Program empowers communities to overpower diabetes

A UW–Madison program aims to give African Americans in Milwaukee strategies to maintain healthy lifestyles that will help prevent and/or manage Type 2 diabetes.

Gene-editing tool now being used to develop better antibiotics

Jason Peters and colleagues have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.

Inflammation biomarker in blood may help predict effectiveness of depression drugs

A simple blood test could help doctors understand what medication might work best for patients at the start of their treatment, according to new UW–Madison research.

Cell therapy is the future, and Wisconsin is the place, UW–Madison expert tells Technology Council

UW–Madison has doctors willing to guide the studies that will make or break cell therapy companies. “If you are a clinician, you need a pioneer spirit to do something that has never been done before,” Jacques Galipeau says, “and there are already many like that here.”

Searching the sea, and bacterial battles, for new antibiotics

Researchers in pharmacy and bacteriology say their discovery would not have been possible without a cross-college collaboration going back nearly a decade.

Forecasting antibiotic resistance with a ‘weather map’ of local data

To help physicians choose the best antibiotic first, researchers in the School of Pharmacy and the State Cartographer's Office are drawing inspiration from the weather.

Over-the-counter drugs: Do we take as directed?

A marketing professor is studying how to discourage people with raging headaches from violating drug label directions. His findings could lead to changes in labeling and improved consumer education.

Vaccine trial aims to make flu season safer for heart patients

A network of researchers in the United States and Canada will try to spare thousands of patients the dangers of heart attacks and hospitalizations over the next five years in a trial of a high-dose flu vaccine.